The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer
Abstract
Colorectal cancer (CRC), one of the most prevalent cancers, has complex etiology. The dysbiosis of intestinal bacteria has been highlighted as an important contributor to CRC. Fusobacterium nucleatum, an oral anaerobic opportunistic pathogen, is enriched in both stools and tumor tissues of patients with CRC. Therefore, F. nucleatum is considered to be a risk factor for CRC. This review summarizes the biological characteristics and the mechanisms underlying the regulatory behavior of F. nucleatum in the tumorigenesis and progression of CRC. F. nucleatum as a marker for the early warning and prognostic prediction of CRC, and as a target for prevention and treatment, is also described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Current understanding of the human microbiome
Gilbert, J. A., Blaser, M. J., Caporaso, J. G., Jansson, J. K., Lynch, S. V., & Knight, R. (2018) · Nature Medicine · doi:10.1038/nm.4517 · Cited by 2,609
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247
The Oral Microbiota: Dynamic Communities and Host Interactions
Lamont, R. J., Koo, H., & Hajishengallis, G. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0089-x · Cited by 2,217
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198
Self-citationFusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
Hajishengallis, G., & Chavakis, T. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00488-6 · Cited by 1,871
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574
Gur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Interactions between the microbiota and pathogenic bacteria in the gut
Bäumler, A. J., & Sperandio, V. (2016) · Nature · doi:10.1038/nature18849 · Cited by 1,420
Functions of N6-methyladenosine and its role in cancer
He, L., Li, H., Wu, A., Peng, Y., Shu, G., & Yin, G. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1109-9 · Cited by 1,397
Wirbel, J., Pyl, P. T., Kartal, E., Zych, K., Kashani, A., Milanese, A., Fleck, J. S., Voigt, A. Y., Palleja, A., Ponnudurai, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0406-6 · Cited by 1,373
Colorectal cancer screening: a global overview of existing programmes
Schreuders, E. H., Ruco, A., Rabeneck, L., Schoen, R. E., Sung, J. J. Y., Young, G. P., & Kuipers, E. J. (2015) · Gut · doi:10.1136/gutjnl-2014-309086 · Cited by 1,328
Oral multispecies biofilm development and the key role of cell–cell distance
Kolenbrander, P. E., Palmer, R. J., Periasamy, S., & Jakubovics, N. S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2381 · Cited by 1,309
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030
Yang, Y., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,008
A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903
Oral Microbial Communities: Biofilms, Interactions, and Genetic Systems
Kolenbrander, P. E. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.413 · Cited by 894
Abed, J., Emgård, J. E. M., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.006 · Cited by 888
Fusobacterium nucleatum: a commensal-turned pathogen
Han, Y. W. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.11.013 · Cited by 827
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
Genetic prognostic and predictive markers in colorectal cancer
Walther, A., Johnstone, E., Swanton, C., Midgley, R., Tomlinson, I., & Kerr, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2645 · Cited by 705
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669
Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections
Löfmark, S., Edlund, C., & Nord, C. E. (2010) · Clinical Infectious Diseases · doi:10.1086/647939 · Cited by 656
The oral microbiota in colorectal cancer is distinctive and predictive
Flemer, B., Warren, R. D., Barrett, M. P., Cisek, K., Das, A., Jeffery, I. B., Hurley, E., O‘Riordain, M., Shanahan, F., & O‘Toole, P. W. (2018) · Gut · doi:10.1136/gutjnl-2017-314814 · Cited by 646
Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
CANAVAN, C., ABRAMS, K. R., & MAYBERRY, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02854.x · Cited by 622
Quraishi, M. N., Widlak, M., Bhala, N., Moore, D., Price, M., Sharma, N., & Iqbal, T. H. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14201 · Cited by 617
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1
Rubinstein, M. R., Baik, J. E., Lagana, S. M., Han, R. P., Raab, W. J., Sahoo, D., Dalerba, P., Wang, T. C., & Han, Y. W. (2019) · EMBO reports · doi:10.15252/embr.201847638 · Cited by 525
Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer
Coker, O. O., Nakatsu, G., Dai, R. Z., Wu, W. K. K., Wong, S. H., Ng, S. C., Chan, F. K. L., Sung, J. J. Y., & Yu, J. (2019) · Gut · doi:10.1136/gutjnl-2018-317178 · Cited by 511
Zheng, D.-W., Dong, X., Pan, P., Chen, K.-W., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0423-2 · Cited by 495
Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.-O., Sugai, T., An, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1865 · Cited by 465
TIGIT and CD 96: new checkpoint receptor targets for cancer immunotherapy
Dougall, W. C., Kurtulus, S., Smyth, M. J., & Anderson, A. C. (2017) · Immunological Reviews · doi:10.1111/imr.12518 · Cited by 435
Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum
Bolstad, A. I., Jensen, H. B., & Bakken, V (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.1.55 · Cited by 423
Baxter, N. T., Ruffin, M. T., Rogers, M. A. M., & Schloss, P. D. (2016) · Genome Medicine · doi:10.1186/s13073-016-0290-3 · Cited by 354
Co-occurrence of anaerobic bacteria in colorectal carcinomas
Warren, R. L., Freeman, D. J., Pleasance, S., Watson, P., Moore, R. A., Cochrane, K., Allen-Vercoe, E., & Holt, R. A. (2013) · Microbiome · doi:10.1186/2049-2618-1-16 · Cited by 348
Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer
Liang, Q., Chiu, J., Chen, Y., Huang, Y., Higashimori, A., Fang, J., Brim, H., Ashktorab, H., Ng, S. C., Ng, S. S. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1599 · Cited by 332
Casasanta, M. A., Yoo, C. C., Udayasuryan, B., Sanders, B. E., Umaña, A., Zhang, Y., Peng, H., Duncan, A. J., Wang, Y., Li, L., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9157 · Cited by 327
Komiya, Y., Shimomura, Y., Higurashi, T., Sugi, Y., Arimoto, J., Umezawa, S., Uchiyama, S., Matsumoto, M., & Nakajima, A. (2019) · Gut · doi:10.1136/gutjnl-2018-316661 · Cited by 316
Zhang, S., Yang, Y., Weng, W., Guo, B., Cai, G., Ma, Y., & Cai, S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0985-y · Cited by 316
Wong, S. H., Kwong, T. N. Y., Chow, T.-C., Luk, A. K. C., Dai, R. Z. W., Nakatsu, G., Lam, T. Y. T., Zhang, L., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312766 · Cited by 310
F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer
Hong, J., Guo, F., Lu, S.-Y., Shen, C., Ma, D., Zhang, X., Xie, Y., Yan, T., Yu, T., Sun, T., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322780 · Cited by 290
Self-citationXu, C., Fan, L., Lin, Y., Shen, W., Qi, Y., Zhang, Y., Chen, Z., Wang, L., Long, Y., Hou, T., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1980347 · Cited by 289
Ito, M., Kanno, S., Nosho, K., Sukawa, Y., Mitsuhashi, K., Kurihara, H., Igarashi, H., Takahashi, T., Tachibana, M., Takahashi, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29488 · Cited by 288
Dong, X., Pan, P., Zheng, D.-W., Bao, P., Zeng, X., & Zhang, X.-Z. (2020) · Science Advances · doi:10.1126/sciadv.aba1590 · Cited by 282
Abed, J., Maalouf, N., Manson, A. L., Earl, A. M., Parhi, L., Emgård, J. E. M., Klutstein, M., Tayeb, S., Almogy, G., Atlan, K. A., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00400 · Cited by 267
Perspective: Alpha-Bugs, Their Microbial Partners, and the Link to Colon Cancer
Sears, C. L., & Pardoll, D. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/jinfdis/jiq061 · Cited by 259
Hamada, T., Zhang, X., Mima, K., Bullman, S., Sukawa, Y., Nowak, J. A., Kosumi, K., Masugi, Y., Twombly, T. S., Cao, Y., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0174 · Cited by 232
Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7
Chen, S., Su, T., Zhang, Y., Lee, A., He, J., Ge, Q., Wang, L., Si, J., Zhuo, W., & Wang, L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1695494 · Cited by 232
Chen, Zhang, L., Li, M., Zhang, Y., Sun, M., Wang, L., Lin, J., Cui, Y., Chen, Q., Jin, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28913-5 · Cited by 232
Guo, P., Tian, Z., Kong, X., Yang, L., Shan, X., Dong, B., Ding, X., Jing, X., Jiang, C., Jiang, N., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01677-w · Cited by 209
Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer
Hur, K., Toiyama, Y., Okugawa, Y., Ide, S., Imaoka, H., Boland, C. R., & Goel, A. (2017) · Gut · doi:10.1136/gutjnl-2014-308737 · Cited by 198
Chen, T., Li, Q., Wu, J., Wu, Y., Peng, W., Li, H., Wang, J., Tang, X., Peng, Y., & Fu, X. (2018) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-018-2233-x · Cited by 195
Cell primitive-based biomimetic functional materials for enhanced cancer therapy
Luo, G.-F., Chen, W.-H., Zeng, X., & Zhang, X.-Z. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00152j · Cited by 193
Chen, Y., Chen, Y., Zhang, J., Cao, P., Su, W., Deng, Y., Zhan, N., Fu, X., Huang, Y., & Dong, W. (2020) · Theranostics · doi:10.7150/thno.38870 · Cited by 188
Kong, C., Yan, X., Zhu, Y., Zhu, H., Luo, Y., Liu, P., Ferrandon, S., Kalady, M. F., Gao, R., He, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0453 · Cited by 186
Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes
Kaplan, C. W., Ma, X., Paranjpe, A., Jewett, A., Lux, R., Kinder-Haake, S., & Shi, W. (2010) · Infection and Immunity · doi:10.1128/iai.00567-10 · Cited by 182
Chen, Y., Peng, Y., Yu, J., Chen, T., Wu, Y., Shi, L., Li, Q., Wu, J., & Fu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.15992 · Cited by 180
Yu, J., Chen, Y., Fu, X., Zhou, X., Peng, Y., Shi, L., Chen, T., & Wu, Y. (2016) · International Journal of Cancer · doi:10.1002/ijc.30168 · Cited by 176
Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients
Li, Y.-Y., Ge, Q.-X., Cao, J., Zhou, Y.-J., Du, Y.-L., Shen, B., Wan, Y.-J. Y., & Nie, Y.-Q. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3227 · Cited by 175
Guo, S., Li, L., Xu, B., Li, M., Zeng, Q., Xiao, H., Xue, Y., Wu, Y., Wang, Y., Liu, W., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.289728 · Cited by 173
Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment
Rad, A. H., Aghebati-Maleki, L., Kafil, H. S., & Abbasi, A. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1765310 · Cited by 165
Xia, X., Wu, W. K. K., Wong, S. H., Liu, D., Kwong, T. N. Y., Nakatsu, G., Yan, P. S., Chuang, Y., Chan, M. W. Y., Coker, O. O., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00847-4 · Cited by 165
Serna, G., Ruíz‐Pace, F., Hernando, J., Alonso, L., Fasani, R., Landolfi, S., Comas, R., Jimenez, J., Élez, E., Bullman, S., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.003 · Cited by 162
Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer
Shi, C., Yang, Y. P., Xia, Y., Okugawa, Y., Yang, J., Liang, Y., Chen, H., Zhang, P., Wang, F., Han, H., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308455 · Cited by 160
Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity
Meng, Q., Gao, Q., Mehrazarin, S., Tangwanichgapong, K., Wang, Y., Huang, Y., Pan, Y., Robinson, S. T., Liu, Z., Zangiabadi, A., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152891 · Cited by 153
Gethings-Behncke, C., Coleman, H. G., Jordão, H. W. T., Longley, D. B., Crawford, N., Murray, L., & Kunzmann, A. T. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1295 · Cited by 151
Hu, L., Liu, Y., Kong, X., Wu, R., Peng, Q., Zhang, Y., Zhou, L., & Duan, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658681 · Cited by 148
Yin, H., Miao, Z., Wang, L., Su, B., Liu, C., Jin, Y. T., Wu, B., Han, H., & Yuan, X. (2022) · Aging · doi:10.18632/aging.203914 · Cited by 116
Zheng, X., Liu, R., Zhou, C., Yu, H., Luo, W., Zhu, J., Liu, J., Zhang, Z., Xie, N., Peng, X., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2273 · Cited by 114
Borowsky, J., Haruki, K., Lau, M. C., Costa, A. D., Väyrynen, J. P., Ugai, T., Arima, K., da Silva, A., Felt, K. D., Zhao, M. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4009 · Cited by 113
Park, H. E., Kim, J. H., Cho, N., Lee, H. S., & Kang, G. H. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2171-6 · Cited by 111
Wang, H., Li, L., Guo, S., Zeng, Q., Ning, F., Liu, W., & Zhang, G. (2016) · Scientific Reports · doi:10.1038/srep33440 · Cited by 106
Corncob formation between Fusobacterium nucleatum and Streptococcus sanguis
Lancy, P., DiRienzo, J. M., Appelbaum, B., Rosan, B., & Holt, S. C. (1983) · Infection and Immunity · doi:10.1128/iai.40.1.303-309.1983 · Cited by 101
Ying, X., Han, X., Guo, S., Xu, B., Liao, Y., Wu, Y., & Zhang, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0389-0 · Cited by 97
Tahara, T., Yamamoto, E., Madireddi, P., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelı́nek, J., Yamano, H.-O., Sugai, T., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.060 · Cited by 91
Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
Brennan, C. A., Nakatsu, G., Gallini, C. A., Drew, D. A., Glickman, J. N., Schoen, R. E., Chan, A. T., & Garrett, W. S. (2021) · mBio · doi:10.1128/mbio.00547-21 · Cited by 87
Sakamoto, Y., Mima, K., Ishimoto, T., Ogata, Y., Imai, K., Miyamoto, Y., Akiyama, T., Daitoku, N., Hiyoshi, Y., Iwatsuki, M., et al. (2021) · Cancer Science · doi:10.1111/cas.15126 · Cited by 87
Gut Microbiota and Colorectal Cancer
Yu, Y.-N., & Fang, J.-Y. (2015) · Gastrointestinal Tumors · doi:10.1159/000380892 · Cited by 82
Self-citationFusobacterium nucleatum Apoptosis-inducing Outer Membrane Protein
Kaplan, C. W., Lux, R., Huynh, T. N., Jewett, A., Shi, W., & Haake, S. K. (2005) · Journal of Dental Research · doi:10.1177/154405910508400803 · Cited by 73
No evidence for colonization of oral bacteria in the distal gut in healthy adults
Rashidi, A., Ebadi, M., Weisdorf, D. J., Costalonga, M., & Staley, C. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114152118 · Cited by 71
de Carvalho, A. C., Pereira, L. D. M., Datorre, J. G., dos Santos, W., Berardinelli, G. N., Matsushita, M., de Oliveira, M. A., Durães, R. O., Guimarães, D. P., & Reis, R. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00813 · Cited by 67
Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation
Galaski, J., Shhadeh, A., Umaña, A., Yoo, C. C., Arpinati, L., Isaacson, B., Berhani, O., Singer, B. B., Slade, D. J., Bachrach, G., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.692544 · Cited by 64
Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer
Yamamoto, S., Kinugasa, H., Hirai, M., Terasawa, H., Yasutomi, E., Oka, S., Ohmori, M., Yamasaki, Y., Inokuchi, T., Harada, K., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15361 · Cited by 62
Sayed, I. M., Chakraborty, A., El‐Hafeez, A. A. A., Sharma, A., Sahan, A. Z., Huang, W. J. M., Sahoo, D., Ghosh, P., Hazra, T. K., & Das, S. (2020) · Cells · doi:10.3390/cells9091980 · Cited by 60
Metagenomic analyses of the gut microbiota associated with colorectal adenoma
Saito, K., Koido, S., Odamaki, T., Kajihara, M., Kato, K., Horiuchi, S., Adachi, S., Arakawa, H., Yoshida, S., Akasu, T., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212406 · Cited by 57
Fusobacterium spp. target human CEACAM1 via the trimeric autotransporter adhesin CbpF
Brewer, M. L., Dymock, D., Brady, R. L., Singer, B. B., Virji, M., & Hill, D. J. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1565043 · Cited by 54
Annexin A1 is involved in resistance to 5-FU in colon cancer cells
Onozawa, H., Saito, M., Saito, K., Kanke, Y., Watanabe, Y., Hayase, S., Sakamoto, W., Ishigame, T., Momma, T., Ohki, S., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5234 · Cited by 46
Grobbee, E. J., Lam, S. Y., Fuhler, G. M., Blakaj, B., Konstantinov, S. R., Bruno, M. J., Peppelenbosch, M. P., Kuipers, E. J., & Spaander, M. C. W. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619890732 · Cited by 42
Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum
Despins, C. A., Brown, S. D., Robinson, A. V., Mungall, A. J. J., Allen‐Vercoe, E., & Holt, R. A. (2021) · mBio · doi:10.1128/mbio.02062-21 · Cited by 41
Bender, E. (2017) · Nature · doi:10.1038/d41586-017-08699-z · Cited by 40
Feng, Y., Zeng, D.-Z., Tong, Y.-N., Lu, X., Dun, G.-D., Tang, B., Zhang, Z.-J., Ye, X.-L., Li, Q., Xie, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215088 · Cited by 38
Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway
Lu, P., Xu, M., Xiong, Z., Zhou, F., & Wang, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s185766 · Cited by 32
Halitosis Vaccines Targeting FomA, a Biofilm-bridging Protein of Fusobacteria nucleatum
Liu, P., Huang, I., Shu, C., & Huang, C. (2013) · Current Molecular Medicine · doi:10.2174/15665240113139990063 · Cited by 30
Colov, E. P., Degett, T. H., Raskov, H., & Gögenür, I. (2020) · Apmis · doi:10.1111/apm.13032 · Cited by 30
Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer
Kurt, M., & Yumuk, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-81171-1 · Cited by 29
Richardson, M., Ren, J., Rubinstein, M. R., Taylor, J. A., Friedman, R. A., Shen, B., & Han, Y. W. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1814120 · Cited by 28
Proteomic analysis of Fusobacterium nucleatum growth in biofilm versus planktonic state
Llama‐Palacios, A., Potupa, O., Sánchez, M. C., Figuero, E., Herrera, D., & Sanz, M. (2020) · Molecular Oral Microbiology · doi:10.1111/omi.12303 · Cited by 25
Butt, J., Jenab, M., Pawlita, M., Overvad, K., Tjønneland, A. M., Olsen, A., Boutron‐Ruault, M., Carbonnel, F., Mancini, F. R., Kaaks, R., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0313 · Cited by 21
Fecal fusobacterium nucleatum for detecting colorectal cancer: a systematic review and meta-analysis
Huang, Q., Peng, Y., & Xie, F. (2018) · The International Journal of Biological Markers · doi:10.1177/1724600818781301 · Cited by 17
Dadashi, M., Hajikhani, B., Faghihloo, E., Owlia, P., Yaslianifard, S., Goudarzi, M., Nasiri, M. J., & Fallah, F. (2020) · Infectious Disorders - Drug Targets · doi:10.2174/1871526520666200720113004 · Cited by 17
Xue, J., Xie, Y., Zou, T., Qian, Y., Kang, Z., Zhou, C., Pan, S., Xia, T., Chen, Y., & Fang, J. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15559 · Cited by 16
Self-citation
Cited by
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Fusobacterium nucleatum carcinogenesis and drug delivery interventions
Chen, Z., & Huang, L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115319 · Cited by 27
Metadata
- Authors
- Wang, N., & Fang, J.-Y.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 31
- Issue
- 2
- Pages
- 159-172
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W4293920863
- Cited by
- 387
- References
- 117
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.